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Acute complications of percutaneous 
transluminal coronary angioplasty for total 
occlusion 
The incidence of major complications after percutaneous coronary angioplasty (PTCA) of a totally 
occluded artery was assessed retrospectively. A total of 1649 PTCA procedures were analyzed. 
After exclusion of procedures for acute myocardial infarction or total occlusion that resulted from 
restenosis, 90 patients were selected. Forty-four patients (49%) had stable angina and 46 (51%) 
had unstable angina. The estimated duration of occlusion was 67 t- 78 days in patients with 
stable angina, as compared with 10 _+ 8 days in patients with unstable angina (p < 0.001). Abrupt 
vessel closure during PTCA occurred only in patients with unstable angina (0% versus 17%, p < 
0.05). The major complication rate was 2.5% in the stable angina group, and 20% in unstable 
angina group (p < 0.01). This rate was also significantly higher than the complication rate of 8% 
observed in 442 procedures that were performed during the same period in patients with the 
unstable angina and nonocclusive stenosis (p < 0.01). Patients with unstable angina who undergo 
PTCA of a totally occluded artery represent a subset at high risk for major complications. (AM 
HEART J 1991;121:417.) 
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Improvements in technology and operator experi- 
ence have led to a greater use of percutaneous trans- 
luminal coronary angioplasty (PTCA) for chronically 
occluded coronary arteries, which now accounts for 
up to 10% of the total number of procedures that are 
performed in large centers.’ Percutaneous recanali- 
zation of an occluded vessel followed by balloon di- 
latation constitutes a reasonable therapeutic alter- 
native to coronary artery bypass surgery (CABG) and 
appears to be a challenging and attractive approach 
in patients with persistent ischemia in spite of an 
optimal drug regimen, especially in the presence of 
single-vessel coronary artery disease. 
From a practical standpoint, coronary artery oc- 
clusion has been traditionally divided into functional 
occlusion and total occlusion.2 Functional occlusion, 
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which is defined as a faint, late anterograde opacifi- 
cation of the vessel lumen distal to the obstruction, 
may rather represent an extremely severe stenosis, 
which has a higher primary success rate of angio- 
plasty, as compared with total occlusion.3-5 In spite of 
a lower primary success rate, PTCA of a total coro- 
nary occlusion (not associated with acute myocardial 
infarction [MI]) has often been considered a rela- 
tively safe and low-risk procedure.3-11 The primary 
success rate is mainly determined by the duration of 
occlusion.3-g The longer the duration, the more the 
lesion is organized and the less is the likelihood of 
recanalization. In relation to the underlying patho- 
physiology of unstable angina pectoris,12q I3 it seems 
conceivable that total occlusion in patients with un- 
stable angina may be of shorter duration and thus 
easier to recanalize. On the other hand, the rate of 
major in-hospital events (MI, emergency revascular- 
ization either by repeat PTCA or CABG, and in-hos- 
pital death) has been shown to be higher in patients 
who undergo PTCA for unstable angina pectoris.14‘1g 
Patients with unstable angina who present with a to- 
tally occluded ischemia-related artery at the time of 
the procedure may even represent a subgroup at 
higher risk for acute complications, since intracoro- 
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nary instrumentation in this particular situation may 
easily result in fragmentation and dislodgement of an 
occlusive intraluminal thrombus. 
Therefore this retrospective study was undertaken 
to assess the incidence of major procedure-related 
complications in patients who underwent PTCA of a 
totally occluded vessel, with a special emphasis on 
patients who present with unstable angina pectoris at 
the time of the procedure. 
METHODS 
Study population. From January 1986 to December 
1988, 1649 PTCA procedures were performed at our insti- 
tution. Angioplasty procedures that were attempted on oc- 
cluded native coronary arteries were retrospectively iden- 
tified from the catheterization laboratory computer data 
base and the corresponding cineangiographic films, and 
reports were reviewed. Total occlusion was defined as 
complete absence of anterograde contrast filling of the in- 
volved coronary artery beyond the site of obstruction. Ac- 
cording to this definition, 153 procedures that were at- 
tempted on totally occluded coronary arteries were initially 
identified. Of these, 63 procedures performed in the setting 
of acute MI or total occlusion that resulted from a previ- 
ous procedure (restenosis) were excluded from the study. 
Thus 90 procedures for total occlusion, which were at- 
tempted in 90 patients, were selected and constituted our 
study group. This group was then subdivided into a group 
with stable angina and a group with unstable angina, 
according to the information that was obtained by review 
of medical records. Unstable angina pectoris was defined as 
progressive angina, angina at rest, or early postinfarction 
angina, as proposed by de Feyter.l* Accordingly, 44 pa- 
tients (49 @r ) were assigned to the stable angina group and 
46 (51 ‘Z ) to the unstable angina group. Of the 46 patients 
with unstable angina, the great majority (36 patients; 78 76 ) 
had either angina at rest or postinfarction angina, whereas 
the remaining 10 patients had progressive angina (new on- 
set angina of a progressive nature or sudden worsening of 
preexisting stable angina). 
All patients had clinical evidence of myocardium viabil- 
ity in the region of distribution of the occluded vessel, as 
documented by ischemic ECG modifications during chest 
pain at rest, exercise test, or thallium-201 scinitigraphy 
and/or on the basis of regional wall motion analysis 
(echocardiography, left ventricular angiography). Patients 
with stable angina were referred for elective PTCA because 
of the persistence of angina1 complaints in spite of optimal 
medical treatment. Patients who presented with unstable 
angina were routinely receiving antiplatelet and heparin 
therapy in addition to their antianginal treatment. 
Angioplasty procedure. PTCA was carried out with a 
preformed 8F guiding catheter, a steerable dilatation sys- 
tem, and a pneumatic inflation device. A 7F pacing elec- 
trode was positioned in the right atrium. Before the proce- 
dure, 10,000 IU of heparin and 250 mg of aspirin were ad- 
ministered intravenously. Four ECG leads (I, II, III and Vs 
for a left anterior descending artery lesion; leads I, II, III 
and V5 for a circumflex artery lesion; and leads I, II, III and 
V5 for a right coronary artery lesion) and aortic pressure 
were monitored continuously. Recanalization was first at- 
tempted by probing the occluded segment with a standard 
soft-tipped guide wire, and if this approach failed, a stiffer 
guide wire was used. “Splinting” of the guide wire with the 
dilatation catheter or a perfusion catheter could also be at- 
tempted to improve its axial strength. After successful re- 
canalization of the occluded segment and appearance of the 
guide wire in the downstream vessel, the intraluminal po- 
sition of the guide wire was generally confirmed by its easy 
mobility or its course in the distal vessel, as seen by anter- 
ograde contrast flow around the guide wire or through col- 
laterals. Thereafter, the dilatation catheter was advanced 
and positioned across the lesion. Depending on the situa- 
tion, contrast injections through the dilatation catheter 
could also be performed to visualize the distal vessel lumen 
beyond the stenosis. Balloon inflation pressure varied from 
2 to 12 atm, and the inflation period ranged from 30 to 180 
seconds. The procedure was carried out with a cardiac sur- 
gical team on standby. Acute coronary closure that was 
presumably caused by thrombus formation, distal embo- 
lization, and residual thrombus at the site of dilatation 
were usually managed with intracoronary thrombolytic 
therapy. 
After angioplasty, arterial and venous sheaths were usu- 
ally left in place, and adequate anticoagulation with intra- 
venous heparin infusion was continued for 24 hours. 
Patients were monitored for 24 hours, and serial ECGs and 
cardiac enzyme levels were obtained. Aspirin (500 mg 
daily) and nifedipine (40 to 60 mg daily) were given after 
the procedure. 
In patients who underwent multivessel PTCA, the oc- 
cluded vessel was usually attempted first. When a coronary 
artery that supplies collaterals had to be dilated, this was 
always performed after an attempt had been made on the 
totally occluded vessel. In patients with unstable angina 
pectoris and multivessel disease, PTCA was usually at- 
tempted on the ischemia-related vessel only.ls The is- 
chemia-related vessel was identified by the correlation of 
ischemic ECG modifications with angiographic findings. 
The totally occluded segment was found to represent the 
culprit lesion in all cases. 
Baseline characteristics. The two groups were com- 
pared for age, gender, history of previous MI in the region 
of distribution of the occluded vessel, and estimated max- 
imal duration of total occlusion. The maximal duration of 
total occlusion was estimated on the basis of the available 
clinical and angiographic information. For instance, in pa- 
tients without a previous angiogram or in patients in whom 
a previous angiogram documented a complete occlusion, 
the maximal potential duration of occlusion was estimated 
as the time interval (in days) between a major change in 
angina1 symptoms (or the occurrence of MI) and the date 
of the procedure. In patients with a previous angiogram 
that showed a nonoccluded segment, the maximal potential 
duration of occlusion was calculated as the time elapsed 
between the date of coronary angiogram and the date of 
PTCA, provided that no clinical events had occurred in the 
meantime. In three patients, the duration of occlusion 
could not be estimated. 
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A consensus by two experienced angiographers was used 
to evaluate angiographic cinefilms. Angiographic success 
was defined as a residual stenosis less than 50 7; , as deter- 
mined by visual assessment. At the time of angiographic 
cinefilm review, the two angiographers were not aware of 
the angina1 status and the clinical evolution of the patients. 
In the few cases in which there was no consensus between 
the two observers, the opinion of a third angiographer was 
solicited. The two subgroups were compared for (1) left 
ventricular ejection fraction, (2) extent of coronary artery 
disease, (3) site of occlusion, (4) estimated length of the 
occluded segment, and (5) angiographic evidence of in- 
traluminal thrombus. Ejection fraction was calculated 
from a 30-degree right anterior oblique cineangiogram of 
the left ventricle. The extent of coronary artery disease was 
defined as the total number of epicardial vessels (or their 
major branches) that contained a visually assessed luminal 
diameter narrowing greater than 50 “0. An attempt was 
made to quantify the length of the nonvisualized coronary 
segment in patients in whom the distal extremity of the 
occlusion could be clearly defined by collateral contrast 
filling of the involved epicardial vessel. This estimation was 
made from the projection most perpendicular to the direc- 
tion of contrast flow to minimize the effects of foreshorten- 
ing. The diameter of the 8F guiding catheter was used as 
a reference for measurement. According to the value ob- 
tained, the estimated length was categorized as I 1 cm, 1 
to 2 cm, or > 2 cm. This measurement could not be ob- 
tained in 23 cases (26?; ), mainly because of poor visualiza- 
tion of the distal vessel lumen. The angiographic criteria for 
the presence of intraluminal thrombus included an intralu- 
minal central filling defect or lucency surrounded by con- 
trast material, that was seen in multiple projections, and 
contrast staining within the lumen or at the site of occlusion. 
AnQioQraphic complications. The occurrence of the 
following angiographic complications was also evaluated 
to obtain a possible association with in-hospital events: 
(1) visible embolization, (2) coronary intimal dissection, 
(3) abrupt vessel reocclusion during PTCA, and (4) dilata- 
tion-induced occlusion of side branches. Embolization was 
defined as an intraluminal central filling defect surrounded 
by contrast material downstream to the site of angioplas- 
ty. Abrupt cutoff of contrast medium observed in the dis- 
tal epicardial vessel or distal side branches was also 
considered to be consistent with embolization. Coronary 
intimal dissection, defined according to the National Heart, 
Lung, and Blood Institute PTCA Registry,20 was catego- 
rized as minor or severe. Minor dissection was defined as a 
linear filling defect that did not compromise vessel lumen 
and did not result in delayed runoff of contrast in the an- 
terograde flow. Severe dissection was defined as contrast 
staining within the vessel wall, contrast extravasation, ex- 
tensive luminal or spiral-shaped filling defect ( L 1 balloon 
length) with delayed runoff of contrast material in the di- 
stal vessel, or dissection that resulted in occlusion of the 
dilated vessel. As suggested by Meier et a1.,21 dilatation- 
induced occlusion of side branches was defined as disap- 
pearance of side branches, stagnation of contrast flow, 
and/or occurrence of filling by collaterals. All angiograph- 
ically visible proximal and involved side branches were in- 
eluded. A side branch was considered to be involved in the 
lesion if its origin was situated in the immediate vicinity of 
the obstruction or if the side branch was subjected to tem- 
porary occlusion while the balloon was inflated. 
In-hospital events. Clinical success was defined as an 
angiographically successful PTCA without any major pro- 
cedure-related complication or recurrence of ischemic 
symptoms during hospitalization. The following in-hospi- 
tal events were considered to be major procedure-related 
complications: (1) periprocedural MI, (2) emergency re- 
vascularization (either repeat PTCA or CABG), and (3) 
in-hospital death. The diagnosis of a periprocedural MI 
was determined by the development of new pathologic Q 
waves on a 12-lead ECG or a typical increase in serum car- 
diac enzymes (more than twice the normal level). Emer- 
gency PTCA was defined as a second procedure during the 
same hospitalization for the occurrence of acute ischemia 
that suggested abrupt vessel closure after a previously suc- 
cessful procedure. Abrupt closure that occurred during the 
initial PTCA session was not considered to be a major 
complication if it was successfully managed by repeat di- 
latation with or without intracoronary infusion of throm- 
bolytic agents and if it did not result in myocardial necro- 
sis. CABG, when performed during the same hospitzaliza- 
tion after failed attempt of recanalization but otherwise 
uncomplicated procedure, was not considered to be a pro- 
cedure-related complication. 
Statistical analysis. Data are presented as mean +- 
standard deviation. Categorical variables were analyzed 
with the chi-square test or Fisher’s exact test, as appropri- 
ate. Continuous variables were analyzed with the unpaired 
Student’s t test. A p value of less than 0.05 was considered 
statistically significant. 
RESULTS 
Baseline characteristics. As shown in Table I, the 
two groups were similar for age, gender, and history 
of previous MI in the region of distribution of the oc- 
cluded vessel. The estimated maximal duration of 
occlusion was shorter in patients with unstable 
angina than in patients with stable angina (10 k 8 
days vs 87 + 78 days, p < 0.001). No statistically 
significant difference was observed between the two 
groups with respect to left ventricular ejection 
fraction, extent of coronary artery disease, site of 
the occluded segment, estimated length of oc- 
clusion, and angiographic evidence for intraluminal 
thrombus. 
AnQioQraphic complications. The occurrence of vis- 
ible embolization, coronary intimal dissection, acute 
reocclusion during PTCA, and occlusion of side 
branches was observed more frequently in patients 
with unstable angina (Table II). However, the only 
significant difference was observed in the frequency 
of abrupt vessel reocclusion during PTCA, which oc- 
curred only in the subgroup of patients with unsta- 
ble angina (0% versus 17%) p < 0.05). 
Success rate and in-hospital events. A residual sig- 
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Table I. Baseline characteristics 
Unstable angina 
ln (%)I p Value 
No. of patients 
Age (yr) 
Gender (male) 
Previous MI* 
Estimated duration 
of occlusion (days) 
Ejection fraction 
Extent of coronary artery disease 
1 -vessel 
2-vessel 
S-vessel 
Site of occluded segment 
RCA 
LAD 
LCX 
Estimated length of occlusion 
51 cm 
l-2 cm 
22 cm 
Unknown 
Intraluminal thrombus 
44 
56.2 rt 9.9 
35 (79.5) 
22 (41) 
a7 I 78 
(range: 10-478) 
0.58 It 0.11 
20 (45.5) 
20 (45.5) 
4 (9) 
20 (45.5) 
13 (29.5) 
11 (25) 
17 (39) 
16 (36) 
1 (2.5) 
10 (22.5) 
2 (5) 
46 
56.7 k 9.5 
31 (67.5) 
19 (40) 
10 L 8 
(range: l-33) 
0.57 + 0.14 
27 (58.5) 
15 (32.5) 
4 (9) 
19 (41) 
20 (44) 
7 (15) 
23 (50) 
9 (20) 
1 (2) 
13 (28) 
6 (13) 
NS 
NS 
NS 
p < 0.001 
NS 
NS 
NS 
NS 
NS 
LAD, Left anterior descending coronary artery; LCX, left circumflex coronary artery: MI, myocardial infarction; NS, not significant; RCA, right coronary 
artery. 
*Previous myocardial infarction in the flow region of the occlused vessel. 
Table II. Angiographic complications* 
Stable 
angina 
In fr-I)] 
Unstable 
angina 
[n (%)I p Value 
No. of patients 44 46 
Visible embolization 2 (9) 8 (23) NS 
Intimal dissection 
Minor 7 (16) 12 (26) NS 
Severe 3 (7) 5 (11) NS 
Acute reocclusion 0 6 (17) p < 0.05 
during PTCA 
Occlusion of side 
branchest 
Proximal l/22 (4.5) 3/18 (17) NS 
Involved 3/31 (10) 5/23 (22) NS 
ETCA, percutaneous transluminal coronary angioplasty; other ahhrevia- 
tions an in Table I. 
*See text for definitions. 
+Thc percentage (in parentheses) represents the number of cases in which 
side-branch occlusion was observed divided by the number of cases in which 
side branches were present. 
nificant stenosis remained after PTCA in one patient 
of each group. As shown in Fig. 1, the immediate an- 
giographic success rate was 48 % in patients with sta- 
ble angina, as compared with 74% in the unstable 
angina group (p < 0.025). One major procedure- 
related complication (MI) was observed in the stable 
angina group after a failed recanalization, which 
leads to a major complication rate of 2.5%. Con- 
versely, 11 in-hospital events occurred in nine pa- 
tients (20 % ) in the unstable angina group (p < 0.01). 
This was observed in five of 11 patients whom 
attempted recanalization failed, and in four of 34 pa- 
tients after an angiographically successful procedure. 
Interestingly, procedure-related complications in pa- 
tients with unstable angina were observed only in 
those who had angina at rest or early postinfarction 
angina. The clinical success rate was 48 % in the sta- 
ble angina group and 65% in the unstable angina 
group (p = 0.09). 
Table III provides additional information on pa- 
tients who sustained in-hospital complications. After 
unsuccessful attempts on the occluded vessel, two 
patients (no. 2 and no. 5) had PTCA of another ves- 
sel that supplies collaterals to the occluded one. In 
these patients, complications were not directly re- 
lated to attempted recanalization of the total occlu- 
sion. However, they were not excluded from the 
analysis since in this particular situation, failure to 
recanalize the occluded segment might have influ- 
enced patient outcome. Nevertheless, the exclusion 
of those two cases from the study would result in a 
complication rate of 16% in the unstable angina 
group (seven of 44 patients), which would remain 
significantly higher than in patients with stable an- 
gina (p < 0.05). 
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Figure 1 Immediate angiographic and clinical success rates and major procedure-related complications 
in patients with stable and unstable angina pectoris who underwent coronary angioplasty of a totally oc- 
cluded artery. *Defined as a residual stenosis less than 50 % , as determined by visual assessment. **Defined 
as angiographically successful dilatation without major procedure-related complication or recurrence of is- 
chemic symptoms during hospitalization. CABG, emergency coronary artery bypass surgery; MI, peripro- 
cedural myocardial infarction; RE-PTCA, emergency coronary angioplasty. 
DISCUSSION 
Safety and efficacy of the procedure. During the first 
years of PTCA, total coronary occlusion was regarded 
as a relative contraindication to the technique. With 
advances in technology and operator experience, 
several groups have reported favorable results, espe- 
cially when the duration of occlusion was estimated 
to be less than 2 months.3-6, 8, g Even if the primary 
success rate is lower than for nonocclusive stenoses, 
balloon angioplasty of a totally occluded coronary 
artery has been regarded as a relatively safe proce- 
dure with a low complication rate.3-g Nevertheless, 
our observations suggest that this rate may not be 
accurate for patients with unstable angina pectoris. 
PTCA and unstable angina. Many reports have al- 
ready shown that the performance of PTCA in 
patients with unstable angina pectoris carries a 
higher risk of acute complications.14-‘g The reasons 
for this high complication rate appear to be related 
to the underlying pathophysiology. In addition to the 
high-grade fixed coronary stenosis that is present in 
almost all patients with unstable angina,22T23 other 
dynamic conditions play a role including plaque fis- 
suring with platelet aggregation; increased vasomo- 
tor tone; and formation of intraluminal throm- 
bus.12, 13, 24-30 There is well-established evidence for 
the rapid development and ubiquity of intraluminal 
thrombosis, which has been derived from angio- 
graphic,31, 32 angioscopic,33 and histopathologic ob- 
servations.i2> l3 It has been demonstrated that the 
presence of preexisting intraluminal thrombus at 
angiography constitutes a risk factor for acute com- 
plications during or shortly after PTCA,“4, 35 which is 
supported by the high rate of abrupt vessel closure 
and major complications that was observed in this 
series in patients with unstable angina. Experimen- 
tal studies have also shown that endothelial denuda- 
tion, platelet adhesion, mural thrombus, and local- 
ized vasoconstriction at the site of dilatation may all 
result from PTCA. 36-38 Thus if performed in the set- 
ting of unstable angina, it seems conceivable that 
balloon dilatation itself may cause further injury to 
the already ulcerated intima and intensify the ongo- 
ing thrombogenic process. 
As stated previously, in-hospital complications 
that were observed in our group of 46 patients with 
unstable angina occurred only among those who had 
angina at rest or early postinfarction angina. This 
observation is in agreement with the findings of Black 
et a1.3g who showed, in a large series, that short du- 
ration of symptoms, angina at rest, and urgent PTCA 
for intractable angina were risk factors for the devel- 
opment of ischemic complications after PTCA. 
Unstable angina and total coronary occlusion. Al- 
though no attempt was made to quantify angiograph- 
ically the volume of intraluminal thrombus, a plau- 
sible reason for the high complication rate that is ob- 
served in patients with unstable angina could be 
related to this variable. In addition to the risk of 
abrupt vessel reocclusion, large intraluminal thrombi 
may lead to an increased risk of embolization. Once 
a complicated coronary lesion has progressed to 
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Table III. Description of major procedure-related complications observed in patients with total coronary occlusion 
Patient 
Age 
fYr) Gender 
Site of 
occ2usion 
Estimated 
duration 
(days) 
In-hospital 
euent(s) Comment 
1 60 
2 53.6 
3 64.7 
4 55.7 
5 65 
6 39.2 
7 54.4 
8 62.7 
9 65.5 
10 69.2 
F 
M 
M 
M 
F 
M 
M 
F 
M 
F 
Stable LAD 20 MI 
Unstable MI 
Unstable MI 
Unstable CABG 
Unstable 
LAD 5 
RCA 3 
LAD 21 
RCA 8 CABG 
MI 
Unstable LAD 10 CABG 
Death 
Unstable LAD 8 MI 
Unstable RCA 3 MI 
Unstable LAD 6 MI 
Unstable RCA 5 re-PTCA 
Occlusion of involved diagonal branch 
during attempted recanalization. 
Elective bypass surgery 19 days 
later. 
Unsuccessful attempt on occluded 
LAD. Occlusion marginal branch 
after PTCA or LCX. 
Occlusion of proximal right ventricular 
branch resulting in loss of collater- 
als. VF - Successful reanimation. 
Jeopardized diagonal branch during 
intracoronary instrumentation. Dis- 
section in proximal LAD. 
Unsuccessful recanalization of RCA. 
Successful PTCA of LCX but 
abrupt closure 7 hours later. Failed 
re-PTCA - CABG. 
Attempted PTCA of proximal 
occluded LAD. Dissection and visi- 
ble thrombus in LCX. BP drop. 
Death in OR. Massive MI. 
Dissection and distal embolization af- 
ter first dilatation. Satisfactory re- 
sults after intracoronary SK and dis- 
tal PTCA. 
Severe fall in BP and HR during 
PTCA after reocclusion of RCA. IV 
atropine, dopamine, and colloids. 
Successful redilatation. 
Occlusion of diagonal branch involved 
in the occluded segment. Normal 
runoff of distal LAD after PTCA. 
Abrupt closure (chest pain, elevated 
ST segment) 19 hours after PTCA. 
Satisfactory results after emergency 
angioplasty. 
BP. L3lood pressure: CABG: emergency coronary artery bypass surgery; F, female: -, subsequent; IV, intravenous; M, male; OR, operating room; re-PTCA, 
emergency coronary angioplasty; SK, streptokinase; VF, ventricular fibrillation; other abbreviations as in Tables I and II. 
complete occlusion, intraluminal thrombus may 
propagate beyond the site of obstruction.40 After re- 
canalization and dilatation, the restored anterograde 
blood flow may “flush” poststenotic thrombotic ma- 
terial toward the distal vascular bed, which may ul- 
timately lead to myocardial necrosis. 
Such a high complication rate in patients with un- 
stable angina may also be related to inadequate col- 
lateral blood supply in the flow region of the occluded 
artery. Patients with unstable angina who present 
with a totally occluded ischemia-related artery might 
have poorer myocardial perfusion of the involved 
flow region as compared to those with persistent an- 
terograde coronary flow. This would potentially lead 
to an increased vulnerability for myocardial necrosis 
after an ischemic insult such as side-branch occlusion 
or distal embolization. Although this study was not 
aimed at assessment of the collateral supply, ade- 
quate visualization of the distal extremity of the oc- 
cluded segment by collateral contrast opacification 
was observed in 33 of the 46 patients with unstable 
angina. Of these 33 patients, six sustained acute 
complications (18% ), in comparison to three of the 
remaining 13 patients with unstable angina (23%) 
with poor or absent collateral filling (p value was not 
significant). Although the number of patients may be 
not sufficient to draw meaningful conclusions, this 
does not support the assumption that absence of an- 
giographically visible collaterals was associated with 
an increased risk of complications. 
Nevertheless, other possible mechanisms that are 
not detectable with conventional coronary angiogra- 
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Table IV. Rate of major complications in 1169 PTCA pro- 
cedures according to the angina1 status and the severity of 
coronary stenosis (from January 1986 to December 1988) 
Non- 
Total occlusive Total 
occlusion stenosis number p Valuet 
Stable angina 
No. of patients 44 637 
with in-hospital 1 (2.5”;) 26 (4”;) “:: (4“, ) = NS 
events 
Unstable angina 
No. of patients 46 442 488 p < 0.025 
with in-hospital 9 (20%) 36 (8’;‘) 4R (9”c.j 
events 
Total no. of 90 1079 1169 
procedures 
p Valuet p < 0.01 p < 0.005 p < 0.0005 
*Excluding coronary angioplasty of saphenous bypass graft. left main COT- 
onary artery, and for restenosis. 
tcomparison of major complications rates between total occlusion and 
nonocclusive stenosis in patients with stable and unstable angina. 
$Comparison of major complication rates between patients with stahle and 
unstable angina for total occlusion, nonocclusive stenosis, and total number 
of patients. 
less favorable than the rate achieved in nonocclusive 
stenosis. Although there was a great variation in in- 
clusion criteria and definitions of coronary occlusion, 
the majority of patients in these previous reports un- 
derwent PTCA for “chronic” total occlusion on an 
elective basis. The complications rate of 2.5% that 
was observed in the present series in patients with 
stable angina is in concordance with previous reports. 
phy may play a role. Pathologic studies in patients 
with unstable angina who died have demonstrated 
that spontaneous embolization of platelet aggregates 
can cause microinfarcts in small intramyocardial 
arteries.l” Furthermore, in situ coronary thrombi 
may contain degranulating platelets, which release 
vasoconstrictors such as thromboxane A2 and 
serotonin.41-4” Leukocytes contained within recent 
thrombi can also produce leukotrienes, which consti- 
tute potent microvascular vasoconstrictors.44-47 Wil- 
son et a1.48 have recently described a syndrome of in- 
tense microvascular constriction after PTCA of acute 
thrombotic coronary lesions, which was attributed to 
the release of potent vasoconstrictors from intralu- 
minal thrombus. In the presence of large, occlusive 
intraluminal thrombus, it seems conceivable that 
mechanical disruption of the clot induced by PTCA 
may further potentiate microembolization or induce 
considerable release of potent vasoconstrictors. How- 
ever, it should be noted that in all patients with total 
coronary occlusion in whom a major complication 
occurred, a plausible “angiographic” explanation 
could be provided, such as abrupt closure, occlusion 
of side branches, or visible embolization. The as- 
sumption that the above mentioned pathophysio- 
logic mechanisms were involved or superimposed re- 
mains purely speculative, and the assessment of such 
processes at the microvascular level was beyond the 
scope of this retrospective clinical study. 
Comparison with nonocclusive stenosis (Table IV). 
During the study period, 1079 PTCA procedures 
were performed on native coronary arteries with 
nonocclusive stenoses (with the exclusion of left main 
PTCA and repeat procedures for restenosis). With 
the same criteria, the major complication rate that 
was observed in 637 elective procedures that were 
performed in patients with stable angina was 4 % (26 
patients), which is similar to the rate of 3 % to 4% 
reported in other series of PTCA in patients with 
stable angina. ‘v 4gy 5o However, in-hospital events oc- 
curred in 8% of 442 PTCA procedures that were per- 
formed on nonocclusive coronary stenoses in patients 
with unstable anigna (p < 0.005). Although this is 
consistent with our previous observations and with 
the major complication rates of 3 % to 12 % reported 
by other investigators, 14-lg this rate remains signifi- 
cantly lower than the rate of 20% observed in the 
subgroup of unstable patients who presented with a 
total coronary occlusion at the time of the procedure 
@ < 0.025). 
However, our observations differ from previous se- 
ries with respect to the number of patients with un- 
stable angina, which may explain, in part, the high 
rate of acute complications. In fact, 46 patients 
(51%) had PTCA in the setting of unstable angina. 
Comparison with previous reports. Many reports 
have demonstrated that the performance of PTCA of 
a total coronary occlusion carries a low risk of acute 
complications,3-10 even if the primary success rate is 
Clinical implications. Since thrombolytic therapy 
combined with PTCA has been widely and safely 
used in the setting of acute MI, it may seem justified 
to apply this strategy to patients with unstable 
angina and total occlusion. We have used throm- 
bolytic therapy in our institution as a “bail out” pro- 
cedure during angioplasty to manage acute coronary 
closure, which was presumably caused by thrombus 
formation.51 However, administration of a throm- 
bolytic agent before attempted mechanical recanal- 
ization of a total occlusion in a patient with unstable 
angina might represent a rational approach. Al- 
though the role of thrombolytic therapy in unstable 
angina pectoris remains uncertain,52, 53 patients with 
total coronary occlusion may represent a subgroup 
that could potentially benefit the most from a strat- 
egy of pretreatment with thrombolytic agents in an 
attempt to reduce the amount of intraluminal throm- 
424 Plante et al. 
bus, stabilize the coronary lesion, and eventually de- 
crease the risk of distal embolization or abrupt ves- 
sel closure. In fact, de Zwaan et a1.53 showed that the 
effect of thrombolytic therapy in patients with un- 
stable angina was most marked in totally occluded or 
severely narrowed vessels, as assessed by quantita- 
tive angiographic analysis. 
The ability of thrombolytic agents to dissolve 
intracoronary thrombus is expected to decrease as 
the duration of occlusion increases and as organiza- 
tion occurs. However, there is some evidence that 
thrombolysis might be effective in coronary occlu- 
sions of longer duration. Prolonged selective infusion 
of urokinase has been used successfully in small se- 
ries to recanalize totally occluded coronary arteries 
and aortocoronary bypass grafts with documented 
thrombosis of 2 to 8 weeks’ duration.54, 55 However, 
the value of such an approach in patients with 
unstable angina who undergo PTCA of a totally oc- 
cluded ischemia-related artery has to be determined 
by further prospective clinical trials. 
Limitations of the study. This retrospective study 
has several limitations. Coronary angiography is the 
only clinical available method to detect the presence 
of intracoronary thrombus, and its sensitivity ap- 
pears to be low in comparison with angioscopic and 
histopathologic observations. Even if the presence of 
intraluminal thrombus is highly suspected in the 
setting of recent coronary occlusion, angiographic 
criteria probably underestimate its frequency to a 
considerable degree. This may explain why intracor- 
onary thrombus was identified in only 13% of our 
patients who had unstable angina before PTCA. An- 
giographic estimation of the length of the nonvisual- 
ized segment may also lack accuracy and lead to 
overestimation in some cases. Furthermore, the in- 
ability to estimate this variable in 23 cases (26%) 
may have resulted in erroneous inferences in the 
study group. 
Additionally, determination of the duration of to- 
tal occlusion on the basis of available clinical and an- 
giographic information constitutes a rough estimate 
of the actual time interval. Although the duration is 
expected to be shorter in patients with unstable an- 
gina, one cannot be certain that the “age” of occlu- 
sion is equivalent to the duration of patients symp- 
toms. 
Finally, the relatively small number of patients 
that was included in this study may introduce the 
possibility of a type II error (failure to demonstrate 
a statistically significant difference when it exists). 
For instance, the observed frequency of visible em- 
bolization after PTCA was higher in patietns with 
unstable angina (9% vs 23%), but no statistical dif- 
1. 
2 
3. 
4. 
5. 
6. 
7. 
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ference could be demonstrated. This may also ex- 
plain why the difference in the clinical success rate 
between the two subgroups (48 % vs 65 % in patients 
with unstable angina did not reach the level of 
statistical significance. 
Conclusions. In spite of these limitations, we be- 
lieve that the occurrence of such a high rate of acute 
complications in patients with unstable angina pec- 
toris (especially in those with angina at rest or 
postinfarction angina) who undergo PTCA of a total 
coronary occlusion should be emphasized. Even if 
recent coronary occlusions have a higher likelihood of 
recanalization, this may be regarded as a “double- 
edged sword” in patients with unstable angina. This 
may be related to the volume of intraluminal throm- 
bus, which in turn may lead to an increased risk of 
embolization or abrupt vessel closure. The major 
complication rate ot 20% that was observed in 
patients with unstable angina was much higher than 
the complication rate of 2.5% in patients with stable 
angina. This rate was also significantly higher than 
the complication rate of 8 % that was observed in pa- 
tients with unstable angina who underwent PTCA of 
nonoccluded vessels during the same period. Patients 
with unstable angina who present with a totally oc- 
cluded ischemia-related artery may constitute a sub- 
set that could potentially benefit from a strategy of 
pretreatment with thrombolytic agents. Further pro- 
spective trials are needed to effectively assess the 
usefulness and safety of this approach. 
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The combined antiischemic effects of the 
thromboxane receptor antagonist SQ 30,74 1 
and tissue-type plasminogen activator 
The thromboxane-receptor antagonist, SQ 30,741, may be used as adjuvant therapy for 
thrombolysis and has also been shown to have antiischemic activity that is independent of its 
thrombolytic activity. Since tissue-type plasminogen activator (CPA) and SQ 30,741 may be 
administered simultaneously, we determined whether the antiischemic effects of SO 30,741 can 
be potentiated by t-PA. This was accomplished by combining doses of t-PA and SQ 30,741, which 
alone were not cardioprotective. Anesthetized dogs were subjected to left circumflex coronary 
artery occlusion for 90 minutes and reperfusion for 5 hours. The dogs were treated during 
reperfusion with a dose of t-PA that caused approximately a 30% reduction in plasma fibrinogen 
alone or in combination with 1.5 mg/kg + 0.4 mg/kg/hr SO 30,741, which started 10 minutes 
after initiation of ischemia. At these doses, neither t-PA nor SO 30,741 alone significantly 
reduced infarct size (57% f 6%, 50% -+ lo%, 57% rfr 6% of the left ventricular area at risk for 
vehicle controls, t-PA, and SQ 30,741 respectively); however, combination treatment resulted in a 
significant reduction in infarct size (37% + 5% of the left ventricular area at risk). Higher doses 
of t-PA and SO 30,741 alone significantly reduced infarct size. The protective effects of t-PA and 
SQ 30,741 occurred without altering peripheral hemodynamic status. No differences in collateral 
or reperfusion blood flow were observed between groups. Thus although SQ 30,741 may act to 
improve the efficacy of thrombolysis, t-PA may in turn enhance the antiischemic activity of SQ 
30,741 or at least reduce the threshold dose. (AM HEART J 1991;121:426.) 
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bolytic agents. Several thrombolytic agents have 
shown efficacy, and among the most interesting are 
activators of plasminogen. One such agent is tissue- 
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